CDK1 and CCNB1 as potential diagnostic markers of rhabdomyosarcoma: validation following bioinformatics analysis

The Ewing Sarcoma Secretome and Its Response to Activation of Wnt/beta-catenin Signaling

(2018) Allegra G. Hawkins et al.   MOLECULAR & CELLULAR PROTEOMICS

Long non-coding RNA SPRY4-IT1 promotes cell proliferation and invasion by regulation of Cdc20 in pancreatic cancer cells

(2018) Wenhao Guo et al.   PLoS One

CDC20 overexpression leads to poor prognosis in solid tumors

(2018) Shengjie Wang et al.   MEDICINE

Identification of genes and analysis of prognostic values in nonsmoking females with non-small cell lung carcinoma by bioinformatics analyses

(2018) Guangda Yang et al.   Cancer Management and Research

Molecular diagnostics in the management of rhabdomyosarcoma

(2017) Michael A. Arnold et al.   EXPERT REVIEW OF MOLECULAR DIAGNOSTICS

let-7b and let-7c microRNAs promote histone H2B ubiquitylation and inhibit cell migration by targeting multiple components of the H2B deubiquitylation machinery

(2017) A Spolverini et al.   ONCOGENE

Prognostic Biomarker Identification Through Integrating the Gene Signatures of Hepatocellular Carcinoma Properties

(2017) Jialin Cai et al.   EBioMedicine

Wnt Signaling in Rhabdomyosarcoma - A Potential Targeted Therapy Option

(2016) Eleanor Chen   CURRENT DRUG TARGETS

Rejection of adenovirus infection is independent of coxsackie and adenovirus receptor expression in cisplatin-resistant human lung cancer cells

(2016) Nian-Hua Zhang et al.   ONCOLOGY REPORTS

Cross-validation of survival associated biomarkers in gastric cancer using transcriptomic data of 1,065 patients

(2016) A. Marcell Szász et al.   Oncotarget

KIF-2C expression is correlated with poor prognosis of operable esophageal squamous cell carcinoma male patients

(2016) Hao Duan et al.   Oncotarget

SLFN11 Is a Transcriptional Target of EWS-FLI1 and a Determinant of Drug Response in Ewing Sarcoma

(2015) S.-W. Tang et al.   CLINICAL CANCER RESEARCH

The synthetic retinoid ST1926 as a novel therapeutic agent in rhabdomyosarcoma

(2015) Hussein Basma et al.   INTERNATIONAL JOURNAL OF CANCER

Distinct methylation profiles characterize fusion-positive and fusion-negative rhabdomyosarcoma

(2015) Wenyue Sun et al.   MODERN PATHOLOGY

Targeting Cdc20 as a novel cancer therapeutic strategy

(2015) Lixia Wang et al.   PHARMACOLOGY & THERAPEUTICS

Kras activation in p53-deficient myoblasts results in high-grade sarcoma formation with impaired myogenic differentiation

(2015) Timothy McKinnon et al.   Oncotarget

MAD1L1 Arg558His and MAD2L1 Leu84Met interaction with smoking increase the risk of colorectal cancer

(2015) Rong Zhong et al.   Scientific Reports

Expression of CDK1Tyr15, pCDK1Thr161, Cyclin B1 (Total) and pCyclin B1Ser126 in Vulvar Squamous Cell Carcinoma and Their Relations with Clinicopatological Features and Prognosis

(2015) Zhihui Wang et al.   PLoS One

Expression Signature Defined by FOXM1-CCNB1 Activation Predicts Disease Recurrence in Non-Muscle-Invasive Bladder Cancer

(2014) S.-K. Kim et al.   CLINICAL CANCER RESEARCH

Chemogenetic Evaluation of the Mitotic Kinesin CENP-E Reveals a Critical Role in Triple-Negative Breast Cancer

(2014) P.-P. Kung et al.   MOLECULAR CANCER THERAPEUTICS

Upregulation of Immunoproteasome Subunits in Myositis Indicates Active Inflammation with Involvement of Antigen Presenting Cells, CD8 T-Cells and IFNγ

(2014) Khetam Ghannam et al.   PLoS One

Targeting PI3K/Akt represses Hypoxia inducible factor-1α activation and sensitizes Rhabdomyosarcoma and Ewing’s sarcoma cells for apoptosis

(2013) Mehtap Kilic-Eren et al.   Cancer Cell International

WHO classification of soft tissue tumours: an update based on the 2013 (4th) edition

(2013) Vickie Y. Jo et al.   PATHOLOGY

Transcriptome correlation analysis identifies two unique craniosynostosis subtypes associated with IRS1 activation

(2012) B. D. Stamper et al.   PHYSIOLOGICAL GENOMICS

Loss of Cytoplasmic CDK1 Predicts Poor Survival in Human Lung Cancer and Confers Chemotherapeutic Resistance

(2011) Chunyu Zhang et al.   PLoS One

Fusion Gene–Negative Alveolar Rhabdomyosarcoma Is Clinically and Molecularly Indistinguishable From Embryonal Rhabdomyosarcoma

(2010) Daniel Williamson et al.   JOURNAL OF CLINICAL ONCOLOGY

Molecular Classification of Rhabdomyosarcoma—Genotypic and Phenotypic Determinants of Diagnosis

(2009) Elai Davicioni et al.   AMERICAN JOURNAL OF PATHOLOGY

HMGA Proteins Up-regulate CCNB2 Gene in Mouse and Human Pituitary Adenomas

(2009) I. De Martino et al.   CANCER RESEARCH

Strategies for discovering novel cancer biomarkers through utilization of emerging technologies

(2008) Vathany Kulasingam et al.   Nature clinical practice. Oncology